Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02479035 · ClinicalTrials.gov registry record · NA

Red Raspberries on Insulin Action and Oxidative Stress

A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT02479035: Completed NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

NCT02479035 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02479035, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the relative bioavailability and absorption/kinetic profile of red raspberry polyphenols consumed with a meal and further to determine the relationship of these findings on meal-associated metabolic- oxidative- and inflammatory- responses in relatively insulin sensitive and insulin resistant individuals.

Primary Outcome

The influence of red raspberry consumption on metabolic markers (insulin and glucose)

Interventions

  • DIETARY_SUPPLEMENT Red raspberry meal 1
  • DIETARY_SUPPLEMENT Red raspberry meal 2
  • DIETARY_SUPPLEMENT Control meal

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2015-06-15
Est. Completion 2018-04-02
Phase NA

What the finished NCT02479035 record still lists

NCT02479035 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 3 interventions - of which Red raspberry meal 1 is the first listed.

NCT02479035 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02479035 about?

NCT02479035 is a clinical study titled "Red Raspberries on Insulin Action and Oxidative Stress". The purpose of this study is to investigate the relative bioavailability and absorption/kinetic profile of red raspberry polyphenols consumed with a meal and further to determine the relationship of these findings on meal-associated metabolic- oxidative- and inflammatory- responses in relatively ins...

What is the current status of trial NCT02479035?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-06-15. Estimated completion is 2018-04-02.

What interventions are being tested in trial NCT02479035?

The interventions under investigation include: Red raspberry meal 1 (DIETARY_SUPPLEMENT), Red raspberry meal 2 (DIETARY_SUPPLEMENT), Control meal (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02479035?

This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02479035's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02479035, the US trial registry maintained by the National Library of Medicine. NCT02479035 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.